l General Information |
Product Name | EPI-001 |
General description | EPI-001 is an androgen receptor N-terminal domain antagonist with IC50 of 6 μM and a selective PPAR-gamma modulator. |
Synonym | 3-[4-[2-[4-(3-chloro-2-hydroxypropoxy)phenyl]propan-2-yl]phenoxy]propane-1,2-diol |
Purity | ≥98.5%(HPLC) | CAS Number | 227947-06-0 |
Formula | C21H27ClO5 | Molecular Weight | 394.89 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/mL |
Ethanol | ≥50mg/mL |
Water | Very slightly soluble |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
